Cargando…
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) sur...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/ https://www.ncbi.nlm.nih.gov/pubmed/38020282 http://dx.doi.org/10.1016/j.waojou.2023.100839 |
_version_ | 1785142283074535424 |
---|---|
author | Castenmiller, Charlotte Nagy, Noémi Anna Kroon, Pascal Zion Auger, Lydia Desgagnés, Réjean Martel, Caroline Mirande, Lucie Morel, Bertrand Roberge, Joannie Stordeur, Virginie Tropper, Guy Vézina, Louis Philipe van Ree, Ronald Gomord, Véronique de Jong, Esther Christina |
author_facet | Castenmiller, Charlotte Nagy, Noémi Anna Kroon, Pascal Zion Auger, Lydia Desgagnés, Réjean Martel, Caroline Mirande, Lucie Morel, Bertrand Roberge, Joannie Stordeur, Virginie Tropper, Guy Vézina, Louis Philipe van Ree, Ronald Gomord, Véronique de Jong, Esther Christina |
author_sort | Castenmiller, Charlotte |
collection | PubMed |
description | INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) surface expressing Ara h 2 at high density have been shown to be very hypoallergenic. Here, we assessed the dendritic cell (DC)-activating and T cell polarization capacity of these peanut-specific eBPs. METHODS: Route and kinetics of eBP uptake were studied by (imaging) flow cytometry using monocyte-derived DCs incubated with fluorescently-labelled Ara h 2 eBPs or natural Ara h 2 (nAra h 2) in the presence or absence of inhibitors that block pathways involved in macropinocytosis, phagocytosis, and/or receptor-mediated uptake. DC activation was monitored by flow cytometry (maturation marker expression) and ELISA (cytokine production). T cell polarization was assessed by co-culturing DCs exposed to Ara h 2 eBPs or nAra h 2 with naïve CD4(+) T cells, followed by flow cytometry assessment of intracellular IFNγ(+) (Th1) and IL-13(+) (Th2), and CD25(+)CD127(-)Foxp3(+) regulatory T cells (Tregs). The suppressive activity of Tregs was tested using a suppressor assay. RESULTS: Ara h 2 eBPs were taken up by DCs through actin-dependent pathways. They activated DCs demonstrated by an induced expression of CD83 and CD86, and production of TNFα, IL-6, and IL-10. eBP-treated DCs polarized naïve CD4(+) T cells towards Th1 cells, while reducing Th2 cell development. Furthermore, eBP-treated DCs induced reduced the frequency of Foxp3(+) Tregs but did not significantly affect T cell IL-10 production or T cells with suppressive capacity. In contrast, DC activation and Th1 cell polarization were not observed for nAra h 2. CONCLUSION: Ara h 2 eBPs activate DCs that subsequently promote Th1 cell polarization and reduce Th2 cell polarization. These characteristics mark Ara h 2 eBPs as a promising novel candidate for peanut AIT. |
format | Online Article Text |
id | pubmed-10679945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-106799452023-11-10 A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 Castenmiller, Charlotte Nagy, Noémi Anna Kroon, Pascal Zion Auger, Lydia Desgagnés, Réjean Martel, Caroline Mirande, Lucie Morel, Bertrand Roberge, Joannie Stordeur, Virginie Tropper, Guy Vézina, Louis Philipe van Ree, Ronald Gomord, Véronique de Jong, Esther Christina World Allergy Organ J Full Length Article INTRODUCTION: As the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces robust desensitization without sustained efficacy, novel treatment options are required. Peanut-specific plant-derived eBioparticles (eBPs) surface expressing Ara h 2 at high density have been shown to be very hypoallergenic. Here, we assessed the dendritic cell (DC)-activating and T cell polarization capacity of these peanut-specific eBPs. METHODS: Route and kinetics of eBP uptake were studied by (imaging) flow cytometry using monocyte-derived DCs incubated with fluorescently-labelled Ara h 2 eBPs or natural Ara h 2 (nAra h 2) in the presence or absence of inhibitors that block pathways involved in macropinocytosis, phagocytosis, and/or receptor-mediated uptake. DC activation was monitored by flow cytometry (maturation marker expression) and ELISA (cytokine production). T cell polarization was assessed by co-culturing DCs exposed to Ara h 2 eBPs or nAra h 2 with naïve CD4(+) T cells, followed by flow cytometry assessment of intracellular IFNγ(+) (Th1) and IL-13(+) (Th2), and CD25(+)CD127(-)Foxp3(+) regulatory T cells (Tregs). The suppressive activity of Tregs was tested using a suppressor assay. RESULTS: Ara h 2 eBPs were taken up by DCs through actin-dependent pathways. They activated DCs demonstrated by an induced expression of CD83 and CD86, and production of TNFα, IL-6, and IL-10. eBP-treated DCs polarized naïve CD4(+) T cells towards Th1 cells, while reducing Th2 cell development. Furthermore, eBP-treated DCs induced reduced the frequency of Foxp3(+) Tregs but did not significantly affect T cell IL-10 production or T cells with suppressive capacity. In contrast, DC activation and Th1 cell polarization were not observed for nAra h 2. CONCLUSION: Ara h 2 eBPs activate DCs that subsequently promote Th1 cell polarization and reduce Th2 cell polarization. These characteristics mark Ara h 2 eBPs as a promising novel candidate for peanut AIT. World Allergy Organization 2023-11-10 /pmc/articles/PMC10679945/ /pubmed/38020282 http://dx.doi.org/10.1016/j.waojou.2023.100839 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Full Length Article Castenmiller, Charlotte Nagy, Noémi Anna Kroon, Pascal Zion Auger, Lydia Desgagnés, Réjean Martel, Caroline Mirande, Lucie Morel, Bertrand Roberge, Joannie Stordeur, Virginie Tropper, Guy Vézina, Louis Philipe van Ree, Ronald Gomord, Véronique de Jong, Esther Christina A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title | A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title_full | A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title_fullStr | A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title_full_unstemmed | A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title_short | A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1 |
title_sort | novel peanut allergy immunotherapy: plant-based enveloped ara h 2 bioparticles activate dendritic cells and polarize t cell responses to th1 |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679945/ https://www.ncbi.nlm.nih.gov/pubmed/38020282 http://dx.doi.org/10.1016/j.waojou.2023.100839 |
work_keys_str_mv | AT castenmillercharlotte anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT nagynoemianna anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT kroonpascalzion anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT augerlydia anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT desgagnesrejean anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT martelcaroline anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT mirandelucie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT morelbertrand anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT robergejoannie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT stordeurvirginie anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT tropperguy anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT vezinalouisphilipe anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT vanreeronald anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT gomordveronique anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT dejongestherchristina anovelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT castenmillercharlotte novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT nagynoemianna novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT kroonpascalzion novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT augerlydia novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT desgagnesrejean novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT martelcaroline novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT mirandelucie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT morelbertrand novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT robergejoannie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT stordeurvirginie novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT tropperguy novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT vezinalouisphilipe novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT vanreeronald novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT gomordveronique novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 AT dejongestherchristina novelpeanutallergyimmunotherapyplantbasedenvelopedarah2bioparticlesactivatedendriticcellsandpolarizetcellresponsestoth1 |